NASDAQ:IKT | Profit Breakdown | Inhibikase Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$0.00-$21.05M-$19.59M
2026-03-31$0.00-$17.84M-$16.38M
2025-12-31-$13.78M-$12.73M
2025-09-30$0.00-$12.77M-$11.93M
2025-06-30$0.00-$10.83M-$9.92M
2025-03-31$0.00-$14.6M-$13.68M
2024-12-31$0.00-$12.93M-$12.13M
2024-09-30$0.00-$5.83M-$5.78M
2024-06-30$0.00-$5.05M-$4.96M
2024-03-31$0.00-$4.78M-$4.65M
2023-12-31$1.00-$4.4M-$4.18M
2023-09-30$79,569.00-$4.77M-$4.6M
2023-06-30$116,410.00-$6.2M-$5.78M
2023-03-31$64,521.00-$4.71M-$4.48M
2022-12-31$63,566.00-$4.33M-$4.28M
2022-09-30$7,291.00-$4.51M-$4.49M
2022-06-30$6,552.00-$4.64M-$4.64M
2022-03-31$46,031.00-$4.64M-$4.64M
2021-12-31$1,944.00-$5.04M-$5.04M
2021-09-30$328,459.00-$4.47M-$4.47M
2021-06-30$1.36M-$2.63M-$2.64M
2021-03-31$1.41M-$2.63M-$2.64M
2020-12-31$170,416.00-$1.2M-$1.21M
2020-09-30$37,680.00-$663,709.00-$670,599.00
2020-06-30$219,585.00-$413,921.00-$421,869.00
2020-03-31$270,787.00-$540,015.00-$547,440.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$51.97M-$48,259.00-$48.26M
2024-12-31$0.00-$28.59M-$27,520.00-$27.52M
2023-12-31$260,501.00-$20.09M-$19.03M
2022-12-31$123,440.00-$18.13M-$18.05M
2021-12-31$3.1M-$14.77M-$14.79M
2020-12-31$698,468.00-$2.82M-$2.85M